Ionis Pharmaceuticals (IONS) Receives a Hold from Stifel Nicolaus

Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Ionis Pharmaceuticals today and set a price target of $68.00.Claim 55% Off TipR...

Raccontata damarkets.businessinsider.com